May 27, 2-3PM EDT
While age is the strongest risk factor for severe COVID-19 outcomes, studies have shown that COVID-19 does not affect all population groups equally. The risk of severe COVID-19 (e.g., hospitalization, admission to the intensive care unit (ICU), intubation or mechanical ventilation, death) increases with the number of underlying medical conditions.
During this COCA Call, presenters will update clinicians on the underlying medical conditions associated with severe COVID-19, describe the methods used to rate the evidence linking conditions to severe COVID-19, review the evidence on risk for conditions included, and provide resources for healthcare providers caring for patients with underlying medical conditions.
If you are unable to attend the live COCA Call, the recording will be available to view on demand on the COCA Call webpage a few hours after the live event ends.
The slide set will be available under “Call Materials” on the COCA Call webpage the day of the call.
Free Continuing Education (CE) will be offered for this COCA Call. Registration is not required.
A few minutes before the webinar starts, please click on the Zoom link to join.
Or one-tap mobile:
US: +16692545252,,1603441171#,,,,
*550222# or +16468287666,,1603441171#,,,,
*550222#
Or Telephone:
+1 669 254 5252 or
+1 646 828 7666 or
+1 669 216 1590 or
+1 551 285 1373
Webinar ID: 160 344 1171
Passcode: 550222
Learning Objectives
At the conclusion of the session, the participant will be able to accomplish the following—
- Discuss methods used to review evidence of association between underlying conditions and severe COVID-19, including two large cohort studies.
- Describe the risk associated with specific underlying conditions from the two cohort studies and studies using other methods.
List resources available for healthcare providers caring for patients with underlying medical conditions.
Presenters
- Kanta Sircar, PhD, MPH
- Clinical Disease Team
- COVID-19 Response
- Centers for Disease Control and Prevention
- John Brooks, MD, MPH
- Chief Medical Officer
- COVID-19 Response
- Centers for Disease Control and Prevention
- Sapna Bamrah Morris, MD, MBA
- Clinical Disease Team Lead
- Health Systems and Worker Safety Task Force
- COVID-19 Response Centers for Disease Control and Prevention
Instructions for Obtaining Continuing Education
To receive continuing education (CE) for WC2922-052721 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – “Underlying Medical Conditions and Severe COVID-19: Evidence-based Information for Healthcare Providers” Thursday, May 27, 2021, please visit TCEO and follow these 9 Simple Steps by Tuesday, June 28, 2021.
To receive continuing education (CE) for WD2922-052721 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – “Underlying Medical Conditions and Severe COVID-19: Evidence-based Information for Healthcare Providers” Thursday, May 27, 2021, (Web on Demand), please visit TCEO and follow these 9 Simple Steps by Thursday, June 29, 2023.
Accreditation Statement
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEUs for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education.
The Universal Activity Number is JA4008229-0000-21-049-L04-P and enduring JA4008229-0000-21-050-H04 course category.
This program has been designated as knowledge based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credits for this program.
AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.
Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC did not accept commercial support for this continuing education activity.